| 聚乙二醇干扰素与拉米夫定治疗HBeAg阳性慢性乙型肝炎疗效比较 |
| |
| 引用本文： | 陈文平. 聚乙二醇干扰素与拉米夫定治疗HBeAg阳性慢性乙型肝炎疗效比较[J]. 海南医学院学报, 2011, 17(9): 1189-1191. DOI: 46-1049/R.20110804.1620.023 |
| |
| 作者姓名： | 陈文平 |
| |
| 作者单位： | 陕西省汉中市汉江职工医院药剂科,陕西汉中,723003 |
| |
| 基金项目： | 海南医学院科研基金资助学报项目(0020110310)~~ |
| |
| 摘 要： | 目的:比较聚乙二醇干扰素与拉米夫定治疗HBeAg阳性慢性乙型肝炎疗效,为临床药物治疗提供参考.方法:HBeAg阳性慢性乙型肝炎患者80例,随机分为观察组与对照组,每组40例,两组均经综合保肝治疗,对照组加用拉米夫定治疗,观察组加用聚乙二醇干扰素治疗,比较治疗前、后两组肝功能指标丙氨酸转氨酶(ALT)、总胆红素(TBIL...
|
| 关 键 词： | HBeAg阳性慢性乙型肝炎 聚乙二醇干扰素 拉米夫定 血清转换率 |
Pegylated interferon and lamivudine treatment of HBeAg-positive chronic hepatitis B treatment comparative analysis |
| |
| Chen Wen-ping. Pegylated interferon and lamivudine treatment of HBeAg-positive chronic hepatitis B treatment comparative analysis[J]. Journal of Hainan Medical College, 2011, 17(9): 1189-1191. DOI: 46-1049/R.20110804.1620.023 |
| |
| Authors: | Chen Wen-ping |
| |
| Affiliation: | Chen Wen-ping(Hanzhong City,Shaanxi Province,Hanzhong,Shaanxi Hanjiang Hospital Pharmacy Staff 723003) |
| |
| Abstract: | Objective: To observe the pegylated interferon and lamivudine treatment of HBeAg-positive chronic hepatitis B treatment comparison to provide reference for clinical drug treatment.Methods: HBeAg-positive chronic hepatitis B of 80 patients divided into two groups according to admission order level-the treatment group and control group 40 cases.Liver in both groups after combined treatment with lamivudine plus control group,the control group were treated with pegylated interferon therapy.Results: The two grou... |
| |
| Keywords: | HBeAg-positive chronic hepatitis B pegylated interferon lamivudine seroconversion rate |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
